Ares Financial Consulting’s Olema Oncology OLMA Stock Holding History
Bought
Maintained
Sold
Other funds holding OLMA
SL
Ares Financial Consulting's OLMA Position: Q3 2026 in Review
Ares Financial Consulting sold out of Olema Oncology (OLMA) in Q3 2026, closing a stake of 24 shares — an estimated $300 sold.
Ares Financial Consulting first reported a position in OLMA in Q2 2026 and held it in 1 quarter. The position peaked at $300 in Q2 2026. 179 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.
- Ares Financial Consulting reported no remaining Olema Oncology position as of Q3 2026 after selling out during the quarter.
- Ares Financial Consulting sold 24 Olema Oncology shares in Q3 2026, an estimated $300.
- Ares Financial Consulting first reported a position in Olema Oncology in Q2 2026 and held it in 1 quarter.
- Ares Financial Consulting's Olema Oncology position peaked at $300 in Q2 2026.
- 179 funds tracked by Wall St. Rank held Olema Oncology as of Q3 2026.
Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.